arrow
K

Kelly A. Ryan

pfizer inc.
H指数:33
被引数:3,467

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy

福特达西罗金-莫瓦帕罗韦克(fordadistrogene movaparvovec)在杜氏肌营养不良症(Duchenne muscular dystrophy)的 Ib 期研究中的补体激活

2025-06-280
PRE
Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trial

福特达斯特罗金莫瓦帕罗韦基(fordadistrogene movaparvovec)基因疗法在杜氏肌营养不良症中的心脏安全性:1b期试验的初步观察

2025-06-280
PREAI
Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis
2023-03-299
OAAI
Correction of depression-associated circadian rhythm abnormalities is associated with lithium response in bipolar disorder
2021-12-0615
OA
Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study
2021-05-0520
OA
The association between lithium use and neurocognitive performance in patients with bipolar disorder
2020-04-2929
OAAI